Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
10.1002/hep.32235 42 KimA.-R.JeonS.-G.ParkS.-J.HongH.KimB
Jennifer Sargent was the primary editor on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team
Bedi, Y
In both trials, FARXIGA reduced the incidence of the primary composite endpoint of CV death, hospitalization for heart failure or urgent heart failure visit (see Table 17)
US$ 20.00
US$ 20.48
US$ 28.21
US$ 21.84
US$ 25.13
US$ 26.43
US$ 22.87
US$ 25.88
US$ 23.28
US$ 26.02
US$ 24.25
US$ 29.32
